A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity?

J Am Acad Dermatol. 2012 Jun;66(6):988-94. doi: 10.1016/j.jaad.2011.09.018. Epub 2011 Dec 9.

Abstract

Background: Linear IgA disease (LAD) has been associated with a variety of drugs over the past 30 years.

Objective: To review current literature on all available cases of drug-induced LAD, in order to ascertain whether a close relationship is justified, so that it constitutes a real and separate nosological entity.

Methods: The PubMed database was searched for all articles written in English related to drug-induced LAD published between January 1980 and December 2010.

Results: The literature review shows that at least 84 articles were published, describing a total of 103 patients. Of these articles, only 46, from 13 countries, were included in this analysis, with a total of 52 patients: 24 (46.2%) were believed to be induced by vancomycin and 28 (53.8%) by drugs other than vancomycin. Challenge-dechallenge-rechallenge testing protocol was performed on only 6 (11.5%) of 52 patients, of which only 5 showed a positive result, while the Naranjo algorithm was performed on only 2 of them (0.3%).

Limitations: The evidence of this review analysis is based only on case reports. No study on large samples of drug-induced LAD is currently available.

Conclusions: The literature analysis reveals no strong scientific evidence to support the notion that some drugs have induced LAD; therefore in many reviewed cases, we must question whether drug-induced LAD is really the underlying entity. Further and thorough investigations using one of the available algorithms for adverse drug reaction are warranted.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Aged
  • Algorithms
  • Anti-Bacterial Agents / adverse effects*
  • Autoimmune Diseases / chemically induced*
  • Autoimmunity / drug effects
  • Female
  • Humans
  • Immunoglobulin A / immunology*
  • Male
  • Middle Aged
  • Skin Diseases, Vesiculobullous / chemically induced*
  • Skin Diseases, Vesiculobullous / immunology
  • Vancomycin / adverse effects*

Substances

  • Anti-Bacterial Agents
  • Immunoglobulin A
  • Vancomycin